JOFABYO

By: Idorsia Pharmaceuticals Ltd

Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases, inflammatory diseases, cancer, auto-immune disorders, neurodegenerative diseases, neurological disorders, anxiety, addictions including addictive eating disorders, neurodegenerative disorders including Alzheimer's disease, diseases of the central nervous system, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, and ...


Logo Design and Free Alerts provided by Trademarks On Call, Inc.

Status Alert: On Wednesday, February 18, 2026, the status for the JOFABYO mark changed to NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER .

On Wednesday, February 18, 2026, a U.S federal trademark application was filed for JOFABYO by Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, Allschwil.

The USPTO has assigned the JOFABYO mark the serial number 99659652. The JOFABYO mark has been filed in the category Pharmaceutical Products.

The owner of the JOFABYO mark is listed as Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, Allschwil. The correspondent for the JOFABYO mark is CORY POKER HOXIE & ASSOCIATES LLC of 75 MAIN STREET, SUITE 203, MILLBURN, NJ 07041, UNITED STATES. If you have licensing, usage or other questions concerning the JOFABYO mark, please contact the owner through the listed correspondent.

The description provided for the JOFABYO mark is Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases, inflammatory diseases, cancer, auto-immune disorders, neurodegenerative diseases, neurological disorders, anxiety, addictions including addictive eating disorders, neurodegenerative disorders including Alzheimer's disease, diseases of the central nervous system, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, and ...
Word Mark: JOFABYO
Status: NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status Date: 02/18/2026
Serial Number: 99659652
Filing Date: 02/18/2026
Registration Number: Not Available
Registration Date: Not Available
Goods and Services: Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases, inflammatory diseases, cancer, auto-immune disorders, neurodegenerative diseases, neurological disorders, anxiety, addictions including addictive eating disorders, neurodegenerative disorders including Alzheimer's disease, diseases of the central nervous system, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, and allergic diseases; Pharmaceutical preparations for the treatment of hypertension, diabetes, and kidney diseases, including chronic kidney disease, diabetic kidney disease, and kidney diseases associated with glycolipid storage disorders and Fabry disease
Type Of Mark: Trademark
Register Type: Principal
Published For Opposition Date: Not Available
Current Owner: Idorsia Pharmaceuticals Ltd
Hegenheimermattweg 91
Allschwil CH-4123
SWITZERLAND
Mark Description: Not Available
Mark Drawing Type: Not Available
Design Search: Not Available
Disclaimer: Not Available
Correspondent: CORY POKER HOXIE & ASSOCIATES LLC
75 MAIN STREET
SUITE 203
MILLBURN, NJ 07041
UNITED STATES
   

 

Class Information

International Class(es):005
US Class(es):005, 006, 018, 044, 046, 051, 052
Primary Class:Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Class(es) Status:Active
First Use Anywhere: Not Available
First Use In Commerce:Not Available
Retrieve Trademark Documents